Jreisat Approach History Age most primary lesions appear in childhood and adolescence while lesions in elderly are usually metastatic Pain indicates nature and site of tumor Swelling ID: 919445
Download Presentation The PPT/PDF document "Malignant Tumors Rahaf" is the property of its rightful owner. Permission is granted to download and print the materials on this web site for personal, non-commercial use only, and to display it on your personal computer provided you do not modify the materials and that you retain all copyright notices contained in the materials. By downloading content from our website, you accept the terms of this agreement.
Slide1
Malignant Tumors
Rahaf
Jreisat
Slide2Approach
History
-Age:
most primary lesions appear in childhood and
adolescence
while lesions in elderly are usually metastatic
-Pain:
indicates nature and site of tumor
-Swelling:
Size indicates tumor
progression
Slide3-Other symptoms:
Fever, weight loss, night sweats
Neurological symptoms (compression)
Examination
-Lump: SPACESPIT
-Lymph nodes
-Joint effusion
-Spine
Slide4Imaging:
Plain X-Ray is the gold standard diagnostic tool
CT: Staging and Mets identification
MRI
Bone Scan: skip lesions
Lab Tests:
CBC, ESR
Alkaline
Phosphatase
Bence
Jones Proteins in urine
Slide5Biopsy:
All imaging studies should be completed before undertaking a biopsy, which may itself distort the appearances.
Tumor biopsy should never be regarded as a ‘minor’ procedure. Complications include
haemorrhage
, wound breakdown, infection and pathological fracture.
Slide6Primary malignant bone tumours
Multiple Myeloma
Osteosarcoma
-Paget Sarcoma
Chondrosacoma
Ewing Sarcoma
■ The most common malignant lesions in bone are metastatic tumors, while the most common primary malignant lesion is Multiple Myeloma.
Slide7Osteosarcoma
a highly malignant
tumour
arising within the bone and spreading rapidly outwards to the
periosteum
and surrounding soft tissues.
The histological appearances show considerable variation.
Slide8Clinical features
occurs predominantly in children and adolescents.
It may affect any bone but most commonly the long-bone
metaphyses
, especially around the knee and at the proximal end of the
humerus
.
Pain is usually the first symptom; it is constant, worse at night and gradually increases in severity.
sometimes the patient presents with a lump.
The erythrocyte sedimentation rate (ESR) is usually raised and there may be an increase in serum alkaline
phosphatase
.
Slide9Imaging
-On x-ray: mixed
lytic
and
blastic
, the
tumour
margins are poorly defined.
-Often the cortex is breached and the
tumour
extends into the adjacent tissues; when this happens, streaks of new bone appear, radiating outwards from the cortex – the so-called ‘sunburst’ effect.
-Where the tumor emerges from the cortex, reactive new bone forms in the angle between
periosteum
and cortex (Codman’s triangle).
About 10% of patients have pulmonary metastases by the time they are first seen which is detected by CT
Slide10Slide11Treatment
Multi-agent chemotherapy is given for 8–12 weeks and then, provided that the tumor is
resectable
and there are no skip lesions, a wide resection is carried out.
It is important to eradicate the primary lesion completely; the mortality rate after local recurrence is far worse than following effective ablation at the first encounter.
Slide12Paget’s sarcoma
Paget’s disease of bone occasionally undergoes malignant transformation; most
osteosarcomas
appearing after the age of 50 years fall into this category.
This
tumour
is more malignant than classic
osteosarcoma
Most patients have pulmonary metastases by the time the
tumour
is diagnosed.
Even with radical resection or amputation and chemotherapy the 5-year survival rate is low.
If the lesion is definitely extra compartmental, palliative treatment by radiotherapy may be preferable; chemotherapy is usually difficult because of the patient’s age and uncertainty about renal and cardiac function.
Slide13Chondrosarcoma
Chondrosarcoma
occurs either as a primary
tumour
or as a secondary change in a pre-existing benign
chondroma
or
osteochondroma
.
Cartilage capped
exostoses
of the pelvis and scapula seem to be more susceptible than others to malignant change, but perhaps this is simply because at these sites the
tumour
can grow without being detected and removed at an early stage.
Slide14Clinical features
highest incidence in the fourth and fifth decades, men are more affected.
Patients may complain of a dull ache or a gradually enlarging lump.
Slide15Imaging
Primary
chondrosarcoma
can occur in any bone that develops in cartilage but is usually seen in the
metaphysis
of long bones. X-ray examination shows a radiolucent area with central flecks of calcification.
Secondary
chondrosarcoma
usually arises in the cartilage cap of an
osteochondroma
that has been present since childhood.
Slide16Slide17Treatment
Chondrosarcomas
are usually slow-growing and metastasize late.
They present the ideal case for wide excision and prosthetic replacement, provided it is certain that the lesion can be completely removed without exposing the
tumour
and without causing an unacceptable loss of function. Otherwise amputation may be a safer option.
The
tumour
does not respond to either radiotherapy or chemotherapy
Slide18Ewing’s sarcoma
Ewing’s sarcoma is believed to arise from endothelial cells in the bone marrow.
Translocation 11/22
It occurs most commonly between the ages of 10 and 20 years, more in males
11 + 22 = 33
Patrick Ewing
Slide19Clinical features
The patient presents with pain – often throbbing in character – and swelling.
Generalized illness and pyrexia, together with a warm, tender swelling and a raised ESR
Slide20imaging
X-ray usually shows an area of bone destruction which, predominantly in the mid
diaphysis
.
New bone formation may extend along the shaft and sometimes it appears as
fusiform
layers of bone around the lesion – the so-called ‘onion-peel’ effect.
Slide21Treatment The prognosis is always poor and surgery alone does little to improve it. Chemotherapy offers a 5-year survival rate of about 50%.
The best results are achieved by a combination of all three methods:
a course of preoperative
neoadjuvant
chemotherapy; then wide excision if the
tumour
is in a
favourable
site, and then a further course of chemotherapy for 1 year.
Slide22Metastatic bone disease
The commonest source is carcinoma of the breast; next in frequency are carcinomas of the prostate, kidney, lung, thyroid, bladder and gastrointestinal tract.
In about 10% of cases no primary
tumour
is found. The commonest sites for bone metastases are the vertebrae, pelvis, the proximal half of the femur and the
humerus
.
Metastases are usually
osteolytic
, and pathological fractures are common.
Osteoblastic
lesions are uncommon; they usually occur in prostatic carcinoma.
Slide23Routes of mets
Hematogenous
: mc route
Lymphatic: rare
Direct implantation like surgical procedures and biopsy
CSF: spread of malignant lesions from
meninges
to vertebrae
Slide24Clinical features
The patient is usually aged 50–70 years; with any destructive bone lesion in this age group, the differential diagnosis must include metastasis.
Pain is the commonest – and often the only – clinical feature.
Symptoms
of
hypercalcaemia
may
occur.
These
include anorexia, nausea, thirst,
polyuria
, abdominal pain, general weakness and depression.
Slide25Imaging
If x-rays do not show anything, a radionuclide scan might. Some deposits remain clinically silent and are discovered incidentally on x-ray, or after a pathological fracture.
Sudden
collapse of a vertebral body or a fracture of the
midshaft
of a long bone in an elderly person are ominous signs; if there is no history and no clinical clue pointing to a primary carcinoma, a biopsy of the fracture area is essential.
Slide26Special investigations
The
ESR may be increased and the
haemoglobin
concentration is usually low.
The
serum alkaline
phosphatase
concentration is often increased, and in prostatic carcinoma the acid
phosphatase
also is elevated
Slide27Treatment
By
the time a patient has developed secondary deposits, the prognosis for survival is almost hopeless.
I
n
the great majority of cases, and certainly in those with multiple
secondaries
, treatment is entirely
symptomatic.
Analgesics, the more powerful narcotics should be reserved for the terminally ill. Unless specifically contraindicated, radiotherapy is used both to control pain and to reduce metastatic growth.
Slide28Secondary
deposits from breast or prostate can often be controlled by hormone
therapy.
Hypercalcaemia
should
be treated by ensuring adequate hydration, reducing the calcium intake and, if necessary, administering
bisphosphonates
.
Slide29Treatment of
shaft
fractures should almost always be treated by internal
fixation.
Spinal stabilization for vertebral fractures. If the spine is stable, a well-fitting brace may be sufficient. However, spinal instability may cause severe pain, making it almost impossible for the patient to sit or stand – with or without a brace. For these patients, operative stabilization is
indicated
Slide30MM
Osteosarcoma
Chondrosarcoma
Ewing sarcoma
Secondary
tumors
Age
6
th
decade
2
nd
and 4
th
decade
4
th
decade
10-20
years
Over 50 years
Symptoms
Pain and swelling
Pain and swelling
Pain, swelling, systemic
symptoms
XRay
Multiple punched out lesions
purely
lytic
Sunburst and
Codman’s triangle
Lytic
and
blastic
calcificatons
Onion-skin
periosteal
reaction
Mostly
lytic
lesions
Tx
Hematological
tx
Surgery for fracture and spinal compression
Neoadjuvant
chemotherapy
and surgery
Surgery
Not sensitive to chemo
or radiation
Neoadjuvant
chemotherapy
and surgery
Surgery is palliative